InvestorsHub Logo

bow-tie

02/28/22 12:53 AM

#26480 RE: Work Harder #26479

ALL RESEARCH OUTPUTS
#18,069,590
of 20,376,777 outputs
OUTPUTS FROM FRONTIERS IN IMMUNOLOGY
#16,368
of 19,094 outputs
OUTPUTS OF SIMILAR AGE
#131,970
of 168,577 outputs
OUTPUTS OF SIMILAR AGE FROM FRONTIERS IN IMMUNOLOGY
#1
of 1 outputs

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2022.

https://frontiers.altmetric.com/details/123533754#score

steel8000

02/28/22 6:48 AM

#26481 RE: Work Harder #26479

So will we get the big bananza??$$ acres of land still to be sold ;)

Work Harder

02/28/22 9:55 AM

#26483 RE: Work Harder #26479

Ruth M. Ruprecht Correspondence:

Dr. Ruth Ruprecht<br/>email:ruth.ruprecht@louisiana.edu<br/>University of Louisiana at Lafayette, New Iberia Research Center

11:41 AM, 10 January 2022

Ruth M. Ruprecht

https://loop.frontiersin.org/people/997152/overview

1 Editorial Contributions

1 Reviewed Publications

https://loop.frontiersin.org/people/997152/editorial

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity

Morgane Bomsel

Published Feb 2021

1,958 views

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167994043

Pg 1 Mymetics / Catalent patent

Other Publications

2011

Bomsel

Leading to the 2013 published vaginal study in women in Ghent Belgium

100 %

Work Harder

02/28/22 12:30 PM

#26486 RE: Work Harder #26479

Chris Gast Director of Statistics - PATH CVIA

Bill & Melinda Gates Foundation.

Biostatistics Consultant, Seattle, Washington.

https://www.linkedin.com/in/chris-gast-301602b0

PATH

Seattle, Washington • 2,500 Employees

International Affairs

https://www.apollo.io/people/Chris/Gast/57dfefa4a6da980ad27cb241

https://rocketreach.co/chris-gast-email_18820546

https://rocketreach.co/c3-research-associates-profile_b5e25031f42e6254

https://www.c3-research.com/

Work Harder

02/28/22 2:54 PM

#26490 RE: Work Harder #26479

Margaret Ackerman on a few w/ Chris Gast

Preprint

&

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees

https://orcid.org/0000-0002-4253-3476

Massachusetts Institute of Technology, Cambridge, MA & Harvard

Ackerman Lab

Dartmouth

https://www.ackermanlab.org/ackerman.html

Specifically, she studied the levels of Immunoglobulin A (IgA) antibodies in their mucus.[11] Her research identified that people who suffered from more mild cases of COVID-19 displayed increased levels of IgA. She also showed that there was an anti-correlation between levels of IgA and IgG, i.e., people with high IgA levels had low IgG levels.[11]

https://en.wikipedia.org/wiki/Margaret_Ackerman

Ref 11

https://engineering.dartmouth.edu/news/milder-cases-of-covid-19-linked-to-iga-antibodies

Georgia D. Tomaras & David Montefiori finally show back up

My, isn't Ruth something else

Work Harder

03/03/22 11:43 AM

#26501 RE: Work Harder #26479

U19AI142636 Publications

https://reporter.nih.gov/search/K-ztMzgyCk25GZC9F4Nb-A/publications?sort_field=pub_year&sort_order=desc

AIDS (London, England) 2021 12 01

AIDS 2021 Dec

Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection

https://pubmed.ncbi.nlm.nih.gov/34402452/

The finish line ?

https://reporter.nih.gov/search/K-ztMzgyCk25GZC9F4Nb-A/projects/charts